PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research Computer Center of Lomonosov Moscow State University, Moscow, Russia; Dimonta Ltd., Moscow, Russia.\', \'Voronezh State University, Voronezh, Russia.\', \'State Research Centre of Virology and Biotechnology \'Vector\', Koltsovo, Russia.\', \'State Research Centre of Virology and Biotechnology \'Vector\', Koltsovo, Russia; Altai State University, Barnaul, Russia.\', \'Altai State University, Barnaul, Russia.\', \'State Research Centre of Virology and Biotechnology \'Vector\', Koltsovo, Russia; Novosibirsk State University, Novosibirsk, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.18097/PBMC20216703259
?:hasPublicationType
?:journal
  • Biomeditsinskaia khimiia
is ?:pmid of
?:pmid
?:pmid
  • 34142533
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • [Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease].
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34142533>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34142533>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all